Chikao Morimoto

Q: What Schools Are Affiliated With Chikao Morimoto

Chikao Morimoto is affiliated with the following schools: Massachusetts General Hospital, Kyoto University, Harvard University, Hokkaido University, MD Anderson Cancer Center, University of Tokyo, Keio University, Institute of Science Tokyo, Juntendo University

Chikao Morimoto's AcademicInfluence.com Rankings

Chikao Morimoto

Computer Science

#5668

World Rank

#5986

Historical Rank

Computational Linguistics

#850

World Rank

#863

Historical Rank

Machine Learning

#1592

World Rank

#1614

Historical Rank

Artificial Intelligence

#1825

World Rank

#1857

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Chikao Morimoto's Degrees

PhD Computer Science University of Tokyo
Masters Computer Science University of Tokyo
Bachelors Computer Science University of Tokyo

Similar Degrees You Can Earn

Why Is Chikao Morimoto Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Chikao Morimoto's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The isolation and characterization of the human suppressor inducer T cell subset. (1985) (829)
The isolation and characterization of the human helper inducer T cell subset. (1985) (700)
Direct association of adenosine deaminase with a T cell activation antigen, CD26. (1993) (511)
B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2. (1991) (448)
Crosstalk between glucocorticoid receptor and nutritional sensor mTOR in skeletal muscle. (2011) (399)
Aqueous extract of Carica papaya leaves exhibits anti-tumor activity and immunomodulatory effects. (2010) (394)
Integrin-mediated Cell Adhesion Promotes Tyrosine Phosphorylation of p130, a Src Homology 3-containing Molecule Having Multiple Src Homology 2-binding Motifs (*) (1995) (346)
B cell subpopulations separated by CD27 and crucial collaboration of CD27+ B cells and helper T cells in immunoglobulin production (1997) (326)
Adhesion of human B cells to germinal centers in vitro involves VLA-4 and INCAM-110. (1990) (314)
Activation of CD4 cells by fibronectin and anti-CD3 antibody. A synergistic effect mediated by the VLA-5 fibronectin receptor complex (1989) (305)
Direct association of pp125FAK with paxillin, the focal adhesion- targeting mechanism of pp125FAK (1995) (263)
Heterogeneity of human T4+ inducer T cells defined by a monoclonal antibody that delineates two functional subpopulations. (1982) (259)
Selective loss of the suppressor-inducer T-cell subset in progressive multiple sclerosis. Analysis with anti-2H4 monoclonal antibody. (1987) (254)
A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes. (1989) (245)
Diet-Induced Adipose Tissue Inflammation and Liver Steatosis Are Prevented by DPP-4 Inhibition in Diabetic Mice (2011) (240)
Generation of plasma cells from peripheral blood memory B cells: synergistic effect of interleukin-10 and CD27/CD70 interaction. (1998) (231)
VLA-4 mediates CD3-dependent CD4+ T cell activation via the CS1 alternatively spliced domain of fibronectin (1990) (227)
Response patterns of purified myeloma cells to hematopoietic growth factors. (1989) (227)
Revisiting an old acquaintance: CD26 and its molecular mechanisms in T cell function. (2008) (226)
Cloning and functional expression of the T cell activation antigen CD26. (1992) (222)
Alterations in immunoregulatory T cell subsets in active systemic lupus erythematosus. (1980) (221)
Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response. (1996) (220)
Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes. (1991) (208)
The role of CD26/dipeptidyl peptidase IV in cancer. (2008) (200)
The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity. (1993) (199)
A defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demonstrated with anti-2H4 antibody. (1987) (196)
CD27-CD70 interactions regulate B-cell activation by T cells. (1995) (195)
Human CD4 helper T cell activation: functional involvement of two distinct collagen receptors, 1F7 and VLA integrin family (1990) (185)
Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1α (SDF-1α) and SDF-1β are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage (1998) (184)
Cyclic regulation of CD45 isoform expression in a long term human CD4+CD45RA+ T cell line. (1991) (182)
1F7, a novel cell surface molecule, involved in helper function of CD4 cells. (1989) (180)
TGF-β1 Reciprocally Controls Chemotaxis of Human Peripheral Blood Monocyte-Derived Dendritic Cells Via Chemokine Receptors (2000) (180)
CD26-mediated signaling for T cell activation occurs in lipid rafts through its association with CD45RO (2001) (170)
Structure and function of Cas-L, a 105-kD Crk-associated substrate- related protein that is involved in beta 1 integrin-mediated signaling in lymphocytes (1996) (169)
Activation of human CD4 T lymphocytes. Interaction of fibronectin with VLA-5 receptor on CD4 cells induces the AP-1 transcription factor. (1991) (155)
Comitogenic effect of solid-phase immobilized anti-1F7 on human CD4 T cell activation via CD3 and CD2 pathways. (1990) (153)
Ligation of VLA-4 on T cells stimulates tyrosine phosphorylation of a 105-kD protein (1992) (152)
CD154/CD40 and CD70/CD27 interactions have different and sequential functions in T cell-dependent B cell responses: enhancement of plasma cell differentiation by CD27 signaling. (1997) (147)
Identification of senescent cell surface targetable protein DPP4 (2017) (144)
TCR Engagement Increases Hypoxia-Inducible Factor-1α Protein Synthesis via Rapamycin-Sensitive Pathway under Hypoxic Conditions in Human Peripheral T Cells1 (2005) (143)
Enhancement of antigen-induced T-cell proliferation by soluble CD26/dipeptidyl peptidase IV. (1994) (137)
The cellular basis for lack of antibody response to hepatitis B vaccine in humans (1991) (131)
MICAL, a Novel CasL Interacting Molecule, Associates with Vimentin* (2002) (130)
Cell surface modulation of CD26 by anti-1F7 monoclonal antibody. Analysis of surface expression and human T cell activation. (1990) (130)
Src kinase plays an essential role in integrin-mediated tyrosine phosphorylation of Crk-associated substrate p130Cas. (1996) (128)
Cross-linking of T3 (CD3) with T4 (CD4) enhances the proliferation of resting T lymphocytes. (1987) (128)
Characterization of CD45 and CD45R monoclonal antibodies using transfected mouse cell lines that express individual human leukocyte common antigens. (1988) (126)
CD27 is a signal-transducing molecule involved in CD45RA+ naive T cell costimulation. (1994) (126)
Evidence for recent as well as long term activation of T cells migrating through endothelial cell monolayers in vitro. (1992) (122)
Internalization of CD26 by mannose 6-phosphate/insulin-like growth factor II receptor contributes to T cell activation. (2000) (122)
CD8+ and CD45RA+ human peripheral blood lymphocytes are potent sources of macrophage inflammatory protein 1α, interleukin‐8 and RANTES (1995) (121)
Role of CD26/dipeptidyl peptidase IV in human T cell activation and function. (2008) (120)
Role of the Glucocorticoid Receptor for Regulation of Hypoxia-dependent Gene Expression* (2003) (120)
CD26 up-regulates expression of CD86 on antigen-presenting cells by means of caveolin-1. (2004) (119)
Role of the VLA-4 molecule in T cell costimulation. Identification of the tyrosine phosphorylation pattern induced by the ligation of VLA-4. (1995) (118)
Determination of adenosine deaminase binding domain on CD26 and its immunoregulatory effect on T cell activation. (1997) (117)
Caveolin-1 Triggers T-cell Activation via CD26 in Association with CARMA1* (2007) (115)
Transcriptional Up-regulation of Inhibitory PAS Domain Protein Gene Expression by Hypoxia-inducible Factor 1 (HIF-1) (2007) (115)
Molecular Interactions, T‐Cell Subsets and a Role of the CD4/CD8:p56lck Complex in Human T‐Cell Activation (1989) (115)
A novel epitope of the LFA-1 antigen which can distinguish killer effector and suppressor cells in human CD8 cells (1987) (112)
Immunodeficiency associated with loss of T4+ inducer T-cell function. (1981) (108)
CD26/dipeptidyl peptidase IV differentially regulates the chemotaxis of T cells and monocytes toward RANTES: possible mechanism for the switch from innate to acquired immune response. (1999) (107)
Autoantibody to an immunoregulatory inducer population in patients with juvenile rheumatoid arthritis. (1981) (105)
Relationship between systemic lupus erythematosus T cell subsets, anti-T cell antibodies, and T cell functions. (1984) (103)
Comodulation of CXCR4 and CD26 in Human Lymphocytes* (2001) (102)
The subdivision of the T4 (CD4) subset on the basis of the differential expression of L-C/T200 antigens (1987) (102)
Human antigen‐specific memory T cells express the homing receptor (LAM‐1) necessary for lymphocyte recirculation (1990) (101)
Dual‐label immunocytochemistry of the active multiple sclerosis lesion: Major histocompatibility complex and activation antigens (1988) (100)
Hypoxia-Inducible Factor Regulates Survival of Antigen Receptor-Driven T Cells 1 (2003) (97)
Abnormalities in CD4+ T-lymphocyte subsets in inflammatory rheumatic diseases. (1988) (94)
CD27/CD70 interaction directly drives B cell IgG and IgM synthesis (1995) (91)
Direct demonstration of the human suppressor inducer subset by anti-T cell antibodies. (1983) (91)
Cross‐linking of CD26 by antibody induces tyrosine phosphorylation and activation of mitogen‐activated protein kinase (1997) (90)
Inhibition of Middle East Respiratory Syndrome Coronavirus Infection by Anti-CD26 Monoclonal Antibody (2013) (90)
The role of the 2H4 molecule in the generation of suppressor function in Con A-activated T cells. (1986) (90)
Serum high molecular weight dipeptidyl peptidase IV (CD26) is similar to a novel antigen DPPT-L released from activated T cells. (1996) (89)
CD134L Engagement Enhances Human B Cell Ig Production: CD154/CD40, CD70/CD27, and CD134/CD134L Interactions Coordinately Regulate T Cell-Dependent B Cell Responses1 (2000) (89)
Humanized Anti-CD26 Monoclonal Antibody as a Treatment for Malignant Mesothelioma Tumors (2007) (88)
Cd26/Dipeptidyl Peptidase IV in Context (1999) (87)
CC chemokine receptors, CCR-1 and CCR-3, are potentially involved in antigen-presenting cell function of human peripheral blood monocyte-derived dendritic cells. (1999) (87)
Subpopulations of the T4+ inducer T cell subset in man: evidence for an amplifier population preferentially expressing Ia antigen upon activation. (1981) (85)
1F7 (CD26): a marker of thymic maturation involved in the differential regulation of the CD3 and CD2 pathways of human thymocyte activation. (1991) (84)
The 2H4 (CD45R) antigen is selectively decreased in multiple sclerosis lesions. (1988) (83)
IL-12 Responsiveness and Expression of IL-12 Receptor in Human Peripheral Blood Monocyte-Derived Dendritic Cells (2000) (81)
Activation of human T cells through CD6: functional effects of a novel anti-CD6 monoclonal antibody and definition of four epitopes of the CD6 glycoprotein. (1993) (81)
Single-cell atlas of colonic CD8+ T cells in ulcerative colitis (2020) (80)
CD26 Mediates Dissociation of Tollip and IRAK-1 from Caveolin-1 and Induces Upregulation of CD86 on Antigen-Presenting Cells (2005) (78)
Biochemical characterization of CD26 (dipeptidyl peptidase IV): functional comparison of distinct epitopes recognized by various anti-CD26 monoclonal antibodies. (1992) (77)
CD31, a novel cell surface marker for CD4 cells of suppressor lineage, unaltered by state of activation. (1992) (76)
Follicular non-Hodgkin's lymphoma cell adhesion to normal germinal centers and neoplastic follicles involves very late antigen-4 and vascular cell adhesion molecule-1. (1992) (76)
Role of CD26/dipeptidyl peptidase IV in human immunodeficiency virus type 1 infection and apoptosis. (1994) (76)
Stimulation of protein tyrosine phosphorylation in human B cells after ligation of the beta 1 integrin VLA-4. (1993) (75)
Characteristics of anti-T-cell antibodies in systemic lupus erythematosus: evidence for selective reactivity with normal suppressor cells defined by monoclonal antibodies. (1980) (75)
In vitro and in vivo antitumor effect of the anti-CD26 monoclonal antibody 1F7 on human CD30+ anaplastic large cell T-cell lymphoma Karpas 299. (2001) (74)
Loss of functional suppression is linked to decreases in circulating suppressor inducer (CD4 + 2H4 +) T Cells in multiple sclerosis (1988) (74)
CD27/CD70 interaction directly induces natural killer cell killing activity (1996) (73)
Soluble CD26/dipeptidyl peptidase IV enhances transendothelial migration via its interaction with mannose 6-phosphate/insulin-like growth factor II receptor. (2002) (72)
CD26‐mediated co‐stimulation in human CD8+ T cells provokes effector function via pro‐inflammatory cytokine production (2013) (72)
Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1alpha (SDF-1alpha) and SDF-1beta are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage. (1998) (71)
Identification of cancer stem cell markers in human malignant mesothelioma cells. (2011) (69)
Dipeptidyl peptidase in autoimmune pathophysiology. (2011) (68)
Negative regulation of the anti‐human immunodeficiency virus and chemotactic activity of human stromal cell‐derived factor 1α by CD26/dipeptidyl peptidase IV (1998) (68)
Reduction of serum soluble CD26/dipeptidyl peptidase IV enzyme activity and its correlation with disease activity in systemic lupus erythematosus. (2002) (68)
Participation of the CD27 antigen in the regulation of IL-2-activated human natural killer cells. (1992) (68)
Correlation between clinical activity of systemic lupus erythematosus and the amounts of DNA in DNA/anti-DNA antibody immune complexes. (1982) (67)
Comparison of lymphokine secretion and mRNA expression in the CD45RA+ and CD45RO+ subsets of human peripheral blood CD4+ and CD8+ lymphocytes (1995) (66)
Functional and phenotypic studies of Japanese adult T cell leukemia cells. (1985) (66)
Soluble CD26/Dipeptidyl Peptidase IV Induces T Cell Proliferation Through CD86 Up-Regulation on APCs1 (2001) (65)
Regulation of epithelial and lymphocyte cell adhesion by adenosine deaminase-CD26 interaction. (2002) (64)
Decrease of suppressor inducer (cd4+ 2h4+) t cells in multiple sclerosis cerebrospinal fluid (1989) (63)
Role of CD27 in T cell immune response. Analysis by recombinant soluble CD27. (1994) (63)
2H1--a novel antigen involved in T lymphocyte triggering. (1988) (63)
SS-A/Ro52, an Autoantigen Involved in CD28-Mediated IL-2 Production 1 (2003) (62)
CD26 regulates p38 mitogen-activated protein kinase-dependent phosphorylation of integrin beta1, adhesion to extracellular matrix, and tumorigenicity of T-anaplastic large cell lymphoma Karpas 299. (2005) (62)
CD27, a member of the nerve growth factor receptor family, is preferentially expressed on CD45RA+ CD4 T cell clones and involved in distinct immunoregulatory functions. (1992) (61)
Communicative interactions between subpopulations of human T lymphocytes required for generation of suppressor effector function in a primary antibody response. (1982) (60)
Interleukin-11 promotes accessory cell-dependent B-cell differentiation in humans. (1992) (60)
B cell co-receptors regulating T cell-dependent antibody production in common variable immunodeficiency: CD27 pathway defects identify subsets of severely immuno-compromised patients. (2001) (60)
The 4F9 antigen is a member of the tetra spans transmembrane protein family and functions as an accessory molecule in T cell activation and adhesion. (1993) (59)
Bilateral Entry and Release of Middle East Respiratory Syndrome Coronavirus Induces Profound Apoptosis of Human Bronchial Epithelial Cells (2013) (58)
Inhibition of dipeptidyl peptidase 4 regulates microvascular endothelial growth induced by inflammatory cytokines. (2010) (58)
Suppression of NF‐κB‐dependent gene expression by a hexamethylene bisacetamide‐inducible protein HEXIM1 in human vascular smooth muscle cells (2003) (57)
CD26 Overexpression Is Associated with Prolonged Survival and Enhanced Chemosensitivity in Malignant Pleural Mesothelioma (2012) (57)
Comparison in T- and B-cell markers in patients with Sjögren's syndrome and systemic lupus erythematosus. (1982) (57)
T-cell activation via CD26 and caveolin-1 in rheumatoid synovium (2006) (57)
Anti-CD26 Monoclonal Antibody–Mediated G1-S Arrest of Human Renal Clear Cell Carcinoma Caki-2 Is Associated with Retinoblastoma Substrate Dephosphorylation, Cyclin-Dependent Kinase 2 Reduction, p27kip1 Enhancement, and Disruption of Binding to the Extracellular Matrix (2006) (55)
Comparative Study of Regulatory T Cell Function of Human CD25+CD4+ T Cells from Thymocytes, Cord Blood, and Adult Peripheral Blood (2008) (55)
The cellular basis for the induction of antigen‐specific T8 suppressor cells (1986) (54)
Direct cellular communications between CD45R0 and CD45RA T cell subsets via CD27/CD70. (1995) (54)
Impact of the Integrin Signaling Adaptor Protein NEDD9 on Prognosis and Metastatic Behavior of Human Lung Cancer (2012) (53)
CD4+CD45RA+ and CD4+CD45RA- T cell subsets in man maintain distinct function and CD45RA expression persists on a subpopulation of CD45RA+ cells after activation with Con A. (1990) (53)
Hypoxia-Inducible Factor Regulates Survival of Antigen Receptor-Driven T Cells (2003) (52)
CD26/dipeptidyl peptidase IV as a novel therapeutic target for cancer and immune disorders. (2007) (51)
CD90 and CD110 correlate with cancer stem cell potentials in human T-acute lymphoblastic leukemia cells. (2009) (51)
Cross‐linking of VLA/CD29 molecule has a co‐mitogenic effect with anti‐CD3 on CD4 cell activation in serum‐free culture system (1991) (50)
Focal Adhesion Kinase (pp125FAK) Is Tyrosine Phosphorylated after Engagement of α4β1 and α5β1 Integrins on Human T-Lymphoblastic Cells (1995) (49)
Regulation of in vitro primary anti-DNP antibody production by functional subsets of T lymphocytes in man. (1981) (49)
The phenotype and reconstitution of immunoregulatory T cell subsets after T cell-depleted allogeneic and autologous bone marrow transplantation. (1994) (49)
First-in-human phase 1 of YS110, a monoclonal antibody directed against CD26 in advanced CD26-expressing cancers (2017) (49)
Prevention of acute graft‐versus‐host disease by humanized anti‐CD26 monoclonal antibody (2013) (48)
CD26: an expanding role in immune regulation and cancer. (2002) (47)
CD11 molecule defines two types of suppressor cells within the T8+ population. (1988) (47)
The 1A4 molecule (CD27) is involved in T cell activation. (1991) (46)
Altered function of suppressor T lymphocytes in patients with active systemic lupus erythematosus--in vitro immune response to autoantigen. (1979) (46)
Chemokine Receptor Expressions and Responsiveness of Cord Blood T Cells (2001) (46)
Tyrosine phosphorylation of Crk-associated substrate lymphocyte-type is a critical element in TCR- and beta 1 integrin-induced T lymphocyte migration. (1999) (46)
In Vitro TNP‐Specific Antibody Formation by Peripheral Lymphocytes from Patients with Systemic Lupus Erythematosus (1977) (46)
Identification of the sequence required for expression of the 2H4 epitope on the human leukocyte common antigens (1987) (45)
Regulation of cancer stem cell properties by CD9 in human B-acute lymphoblastic leukemia. (2011) (45)
Histamine H1‐receptor antagonists with immunomodulating activities: potential use for modulating T helper type 1 (Th1)/Th2 cytokine imbalance and inflammatory responses in allergic diseases (2009) (45)
Beta 1-integrin-mediated cell signaling in T lymphocytes. (2000) (44)
Reactivity of inducer cell subsets and T8-cell activation during the human autologous mixed lymphocyte reaction. (1984) (44)
The functional heterogeneity of CD8+ cells defined by anti-CD45RA (2H4) and anti-CD29 (4B4) antibodies. (1990) (43)
CD9 correlates with cancer stem cell potentials in human B-acute lymphoblastic leukemia cells. (2009) (43)
Effect of activation of protein kinase C on CD45 isoform expression and CD45 protein tyrosine phosphatase activity in T cells (1990) (42)
Good or evil: CD26 and HIV infection. (2000) (42)
HEXIM1 forms a transcriptionally abortive complex with glucocorticoid receptor without involving 7SK RNA and positive transcription elongation factor b. (2005) (42)
TRAIL-Transduced Dendritic Cells Protect Mice from Acute Graft-versus-Host Disease and Leukemia Relapse1 (2005) (42)
The alternative splicing of the CD45 tyrosine phosphatase is controlled by negative regulatory trans-acting splicing factors. (1992) (41)
Cas-L is required for beta 1 integrin-mediated costimulation in human Tcells. (1999) (41)
Structural characterization of CD6: properties of two distinct epitopes involved in T cell activation. (1989) (40)
Regulatory interactions between members of the immunoglobulin superfamily. (1988) (38)
The tetraspanin CD9 is preferentially expressed on the human CD4+CD45RA+ naive T cell population and is involved in T cell activation (2004) (38)
Generation of CD8 (T8) cytotoxic cells has a preferential requirement for CD4+2H4- inducer cells. (1988) (38)
Cellular mechanism of DNA-specific antibody synthesis by lymphocytes from systemic lupus erythematosus patients. (1984) (37)
Antilymphocyte antibodies against CD4+2H4+ cell populations in patients with systemic lupus erythematosus. (1989) (37)
T‐large granular lymphocyte lymphoproliferative disorder: expression of CD26 as a marker of clinically aggressive disease and characterization of marrow inhibition (2003) (37)
Regulation of Pulmonary Graft-versus-Host Disease by IL-26+CD26+CD4 T Lymphocytes (2015) (36)
Association of CD26 with CD45RA outside lipid rafts attenuates cord blood T-cell activation. (2004) (36)
Stimulation of tyrosine phosphorylation after ligation of beta7 and beta1 integrins on human B cells. (1996) (36)
Correlation of the epitopes defined by anti-CD26 mAbs and CD26 function. (1998) (35)
Requirement of Fas(CD95), CD45, and CD11a/CD18 in monocyte-dependent apoptosis of human T cells. (1996) (35)
Core 2-containing O-glycans on CD43 are preferentially expressed in the memory subset of human CD4 T cells. (1999) (34)
Activation of human cytolytic cells through CD2/T11. Comparison of the requirements for the induction and direction of lysis of tumor targets by T cells and NK cells. (1989) (34)
Ligand-based gene expression profiling reveals novel roles of glucocorticoid receptor in cardiac metabolism. (2009) (34)
In Vitro Immune Response of SLE Lymphocytes (1982) (34)
Studies of Anti‐lymphocyte Antibody of Patients with Active SLE (1979) (34)
Signaling events following chemokine receptor ligation in human dendritic cells at different developmental stages. (2001) (34)
Caveolin‐1 is a novel immunohistochemical marker to differentiate epithelioid mesothelioma from lung adenocarcinoma (2009) (33)
CD4CD45R cells are preferentially activated through the CD2 pathway (1988) (33)
A novel mechanism for imatinib mesylate (STI571) resistance in CML cell line KT-1: role of TC-PTP in modulating signals downstream from the BCR-ABL fusion protein. (2004) (33)
G1/S cell cycle arrest provoked in human T cells by antibody to CD26 (2002) (33)
Expression of CD26 and its associated dipeptidyl peptidase IV enzyme activity enhances sensitivity to doxorubicin-induced cell cycle arrest at the G(2)/M checkpoint. (2001) (32)
Distinctive signaling pathways through CD82 and β1 integrins in human T cells (2002) (32)
Ligation of the T cell antigen receptor induces tyrosine phosphorylation of p105CasL, a member of the p130Cas‐related docking protein family, and its subsequent binding to the Src homology 2 domain of c‐Crk (1997) (32)
Nuclear Localization of CD26 Induced by a Humanized Monoclonal Antibody Inhibits Tumor Cell Growth by Modulating of POLR2A Transcription (2013) (32)
Biological Effects of IL-26 on T Cell-Mediated Skin Inflammation, Including Psoriasis. (2019) (32)
Role of the 2H4 molecule in the activation of suppressor inducer function (1988) (32)
The 2H4 molecule but not the T3-receptor complex is involved in suppressor inducer signals in the AMLR system. (1987) (31)
Tyrosine phosphorylation of the product of the c-cbl protooncogene is [corrected] induced after integrin stimulation. (1997) (31)
Mechanisms of confluence-dependent expression of CD26 in colon cancer cell lines (2011) (31)
Systemic Lupus Erythematosus: Delineation of Subpopulations by Clinical, Serologic, and T Cell Subset Analysis (1985) (31)
Characterization of cancer stem cell properties of CD24 and CD26-positive human malignant mesothelioma cells. (2012) (30)
Immunoregulatory human T lymphocytes triggered as a consequence of viral infection: clonal analysis of helper, suppressor inducer and suppressor effector cell populations. (1983) (30)
CD9 Negatively Regulates CD26 Expression and Inhibits CD26-Mediated Enhancement of Invasive Potential of Malignant Mesothelioma Cells (2014) (30)
CD27 and CD40 Inhibit p53-independent Mitochondrial Pathways in Apoptosis of B Cells Induced by B Cell Receptor Ligation* (2002) (30)
Restoration of T-cell function in aged mice with long-term administration of levamisole. (1979) (29)
Cytokine Receptor Common β Subunit-mediated STAT5 Activation Confers NF-κB Activation in Murine proB Cell Line Ba/F3 Cells* (2002) (29)
Regulation of p38 phosphorylation and topoisomerase IIalpha expression in the B-cell lymphoma line Jiyoye by CD26/dipeptidyl peptidase IV is associated with enhanced in vitro and in vivo sensitivity to doxorubicin. (2005) (29)
Defective expression of the 2H4 molecule after autologous mixed lymphocyte reaction activation in systemic lupus erythematosus patients. (1988) (29)
The T4 molecule differentially regulating the activation of subpopulations of T4+ cells. (1987) (29)
Overexpression of CD26/DPPIV in mesothelioma tissue and mesothelioma cell lines. (2011) (29)
Human T cells can be directed to lyse tumor targets through the alternative activation/T11-E rosette receptor pathway. (1988) (28)
Polyarthropathy in type 2 diabetes patients treated with DPP4 inhibitors. (2013) (28)
Quantitation and cloning of human urushiol specific peripheral blood T-cells: isolation of urushiol triggered suppressor T-cells. (1989) (27)
Decreased dipeptidyl peptidase IV enzyme activity of plasma soluble CD26 and its inverse correlation with HIV-1 RNA in HIV-1 infected individuals. (1999) (27)
Blockade of CD26 Signaling Inhibits Human Osteoclast Development (2014) (26)
The role of the macrophage in in vitro primary anti-DNP antibody production in man. (1981) (26)
Activation of mitogen-activated protein kinase through α5/β1 integrin is required for cell cycle progression of B progenitor cell line, Reh, on human marrow stromal cells (2000) (25)
Ebastine inhibits T cell migration, production of Th2‐type cytokines and proinflammatory cytokines (2003) (25)
P. Rambotti Lecture. Human naive and memory T cells revisited: new markers (CD31 and CD27) that help define CD4+ T cell subsets. (1993) (25)
Crk-associated substrate lymphocyte type regulates transforming growth factor-β signaling by inhibiting Smad6 and Smad7 (2007) (25)
In vitro nucleoside specific immune response by lymphocytes from systemic lupus erythematosus. (1983) (24)
Distinct Interaction of Cortivazol with the Ligand Binding Domain Confers Glucocorticoid Receptor Specificity (2002) (24)
Blockade of CD26-mediated T cell costimulation with soluble caveolin-1-Ig fusion protein induces anergy in CD4+T cells. (2009) (24)
An Abortive Ligand-Induced Activation of CCR1-Mediated Downstream Signaling Event and a Deficiency of CCR5 Expression Are Associated with the Hyporesponsiveness of Human Naive CD4+ T Cells to CCL3 and CCL51 (2002) (23)
Interleukin-12 induces tyrosine phosphorylation of an 85-kDa protein associated with the interleukin-12 receptor beta 1 subunit. (1998) (23)
Cytomegalovirus (CMV) retinitis and CMV antigenemia as a clue to impaired adrenocortical function in patients with AIDS (1997) (23)
Structure of CD26 (dipeptidyl peptidase IV) and function in human T cell activation. (1997) (23)
The CD70-CD27 interaction during the stimulation with dendritic cells promotes naive CD4(+) T cells to develop into T cells producing a broad array of immunostimulatory cytokines in humans. (2009) (22)
CD26+ T cells in the pathogenesis of asthma (2005) (22)
DPP4 in anti-tumor immunity: going beyond the enzyme (2015) (22)
Generation of antigen-specific suppressor cells in vitro in man. (1983) (22)
CD26/dipeptidyl peptidase IV enhances expression of topoisomerase II alpha and sensitivity to apoptosis induced by topoisomerase II inhibitors (2003) (22)
Urushiol (poison ivy)-triggered suppressor T cell clone generated from peripheral blood. (1988) (22)
VLA-4-mediated signaling. (1998) (22)
Roxithromycin specifically inhibits development of collagen induced arthritis and production of proinflammatory cytokines by human T cells and macrophages. (2005) (22)
Cytokine receptor common beta subunit-mediated STAT5 activation confers NF-kappa B activation in murine proB cell line Ba/F3 cells. (2002) (22)
Differential effects of cytokines on proliferative response of human CD4+ T lymphocyte subsets stimulated via T cell receptor-CD3 complex. (1990) (21)
Stem cell properties and the side population cells as a target for interferon-alpha in adult T-cell leukemia/lymphoma. (2007) (21)
CD26 Expression on T-Anaplastic Large Cell Lymphoma (ALCL) Line Karpas 299 is associated with increased expression of Versican and MT1-MMP and enhanced adhesion (2013) (21)
Localization of CD26/DPPIV in nucleus and its nuclear translocation enhanced by anti-CD26 monoclonal antibody with anti-tumor effect (2009) (20)
Primary in vitro anti-KLH antibody formation by peripheral blood lymphocytes in man: detection with a radioimmunoassay. (1981) (20)
HTLV-I Tax induces and associates with Crk-associated substrate lymphocyte type (Cas-L) (2005) (20)
A novel role for CD26/dipeptidyl peptidase IV as a therapeutic target. (2018) (20)
CD26-Mediated Induction of EGR2 and IL-10 as Potential Regulatory Mechanism for CD26 Costimulatory Pathway (2015) (20)
Knockdown of XAB2 enhances all-trans retinoic acid-induced cellular differentiation in all-trans retinoic acid-sensitive and -resistant cancer cells. (2007) (19)
CD26-mediated regulation of periostin expression contributes to migration and invasion of malignant pleural mesothelioma cells. (2014) (19)
Differential CD26-mediated activation of the CD3 and CD2 pathways after CD6-depleted allogeneic bone marrow transplantation. (1995) (19)
Regulation of somatostatin receptor 4-mediated cytostatic effects by CD26 in malignant pleural mesothelioma (2014) (19)
Evidence of Aberration of T‐cell Subsets in Aged Individuals (1981) (18)
Novel in vitro effects of bucillamine: inhibitory effects on proinflammatory cytokine production and transendothelial migration of T cells. (2000) (18)
CD26 expression is attenuated by TGF‐β and SDF‐1 autocrine signaling on stromal myofibroblasts in human breast cancers (2019) (18)
Cell-mediated immune response in idiopathic thrombocytopenic purpura. In vitro cellular response to autologous and homologous platelet and platelet membrane by macrophage inhibitory test. (1977) (18)
Role of CD26 for CD4 memory T cell function and activation. (1996) (18)
CD26 expression on T cell lines increases SDF-1-α-mediated invasion (2009) (18)
Direct Association of pp125 Fpa~ with PaxiUin, the Focal Adhesion-targeti ng Mechanism of pp125 F~a~ (1995) (17)
Influence of CD26 and integrins on the antigen sensitivity of human memory T cells. (1996) (17)
The distinct agonistic properties of the phenylpyrazolosteroid cortivazol reveal interdomain communication within the glucocorticoid receptor. (2005) (17)
Cardiomyocyte-Specific Overexpression of HEXIM1 Prevents Right Ventricular Hypertrophy in Hypoxia-Induced Pulmonary Hypertension in Mice (2012) (17)
The Cellular Basis of Impaired T Lymphocyte Functions in the Elderly (1980) (17)
DPP8 is a novel therapeutic target for multiple myeloma (2019) (16)
Antilymphocyte antibodies and systemic lupus erythematosus. (1987) (16)
Pentostatin in T-non-Hodgkin's lymphomas: efficacy and effect on CD26+ T lymphocytes. (2003) (16)
Fibronectin promotes cell proliferation of human pre-B cell line via its interactions with VLA-4 and VLA-5 (2008) (16)
Activation of T cells through a T cell-specific epitope of CD45. (1992) (16)
A humanized anti-CD26 monoclonal antibody inhibits cell growth of malignant mesothelioma via retarded G2/M cell cycle transition (2016) (16)
CD27/CD70 interaction contributes to the activation and the function of human autoreactive CD27+ regulatory T cells. (1997) (15)
Effect of CD26/dipeptidyl peptidase IV on Jurkat sensitivity to G2/M arrest induced by topoisomerase II inhibitors (2003) (15)
Development of an antigen-specific CD8 suppressor effector clone in man. (1988) (15)
CD26 is a potential therapeutic target by humanized monoclonal antibody for the treatment of multiple myeloma (2018) (15)
Human CD4/CD45RA+ and CD4/CD45RA- T cell subsets express CD4-p56lck complexes, CD4-associated lipid kinases, TCR/CD3-p59fyn complexes, and share similar tyrosine kinase substrates. (1993) (14)
Depletion of the helper/inducer (memory) T cell subset using a bispecific antibody-toxin conjugate directed against CD4 and CD29. (1993) (14)
Anti‐human CD9 antibody Fab fragment impairs the internalization of extracellular vesicles and the nuclear transfer of their cargo proteins (2019) (14)
Role of Crk-associated substrate lymphocyte type in the pathophysiology of rheumatoid arthritis in tax transgenic mice and in humans. (2003) (14)
CD9 expression as a favorable prognostic marker for patients with malignant mesothelioma (2012) (14)
Activation of Human Monocytes for Enhanced Production of Interleukin 8 During Transendothelial Migration in Vitro (2004) (14)
Prolonged impairment of very late activating antigen-mediated T cell proliferation via the CD3 pathway after T cell-depleted allogeneic bone marrow transplantation. (1994) (14)
Suppressor T cell function in patients with rheumatoid arthritis complicated by vasculitis. (1984) (13)
Identification of Nedd9 as a TGF-β-Smad2/3 Target Gene Involved in RANKL-Induced Osteoclastogenesis by Comprehensive Analysis (2016) (13)
In vitro anti-DNA antibody synthesis by peripheral blood lymphocytes in patients with systemic lupus erythematosus. (1981) (13)
Optimal stimulation for CD70 induction on human monocyte‐derived dendritic cells and the importance of CD70 in naive CD4+ T‐cell differentiation (2010) (13)
Anti-T cell antibody in juvenile rheumatoid arthritis. (1984) (13)
Effects of repetitive transcranial magnetic stimulation on ER stress-related genes and glutamate, γ-aminobutyric acid and glycine transporter genes in mouse brain (2018) (13)
Establishment of monoclonal anti-human CD26 antibodies suitable for immunostaining of formalin-fixed tissue (2014) (13)
Could Serum Antibody to Poly(ADP‐Ribose) and/or Histone H1 Be Marker for Senile Dementia of Alzheimer Type? (2007) (12)
Focal adhesion kinase (pp125FAK) is tyrosine phosphorylated after engagement of alpha 4 beta 1 and alpha 5 beta 1 integrins on human T-lymphoblastic cells. (1995) (12)
Adhesion of follicular lymphoma cells to lymphoid germinal centers--a potential mechanism of tumor cell homing following autologous transplantation. (1994) (12)
Development of a monoclonal antibody, anti-6C2, which is involved in the interaction of CD4 T helper cells and activated B cells. (1991) (11)
Selective inhibition of anti-nucleoside-specific antibody production by nucleoside-ricin A conjugate. (1983) (11)
Clinical Significance of Soluble CD26 in Malignant Pleural Mesothelioma (2014) (11)
SSA/Ro52 autoantigen interacts with Dcp2 to enhance its decapping activity. (2008) (11)
Different Regulatory Effects of Pentoxifylline on Human T Cell Activation Pathways (1997) (11)
Studies of Anti‐Lymphocyte Antibody in Patients with Active SLE (1980) (10)
Aberrant responsiveness to RANTES in synovial fluid T cells from patients with rheumatoid arthritis. (2002) (10)
Activation of mitogen-activated protein kinase through alpha5/beta1 integrin is required for cell cycle progression of B progenitor cell line, Reh, on human marrow stromal cells. (2000) (10)
Role of the hinge region of glucocorticoid receptor for HEXIM1-mediated transcriptional repression. (2008) (10)
In Vitro and in Vivo Antitumor Effect of the Anti-CD 26 Monoclonal Antibody 1 F 7 on Human CD 30 1 Anaplastic Large Cell T-Cell Lymphoma Karpas 2991 (2001) (10)
A possible role for CD26/DPPIV enzyme activity in the regulation of psoriatic pruritus. (2017) (10)
Requirements for the construction of antibody heterodimers for the direction of lysis of tumors by human T cells. (1988) (10)
Direct demonstration of the CD27 molecule involved in the negative regulatory effect on T cell activation. (1993) (10)
Phenotypic abnormalities in CD8+ T lymphocyte subsets in patients with rheumatoid arthritis. (1991) (9)
CD26/Dipeptidyl Peptidase IV and Its Multiple Biological Functions (2021) (9)
Rheumatic diseases associated with immune checkpoint inhibitors in cancer immunotherapy (2018) (9)
Cellular interaction between subsets of T8 population for maximal suppression of antigen-specific antibody response. (1984) (9)
Novel Antibody-Drug Conjugate with Anti-CD26 Humanized Monoclonal Antibody and Transcription Factor IIH (TFIIH) Inhibitor, Triptolide, Inhibits Tumor Growth via Impairing mRNA Synthesis (2019) (9)
Comparison of Two Commercial ELISAs against an In‐House ELISA for Measuring Soluble CD26 in Human Serum (2015) (9)
Characterization of novel anti-IL-26 neutralizing monoclonal antibodies for the treatment of inflammatory diseases including psoriasis (2019) (9)
Lymphocyte Migration Integrin-Induced T 1 b Element in TCR- and Substrate Lymphocyte-Type Is a Critical Tyrosine Phosphorylation of Crk-Associated (1999) (8)
CD45 isoforms associated with distinct functions of CD4 cells derived from unusual healthy donors lacking CD45RA- T lymphocytes. (1991) (8)
Multiple effects of repetitive transcranial magnetic stimulation on neuropsychiatric disorders. (2013) (8)
Inhibition of VEGF-dependent angiogenesis by the anti-CD82 monoclonal antibody 4F9 through regulation of lipid raft microdomains. (2016) (8)
Targeting of an Activated T-cell Subset Using a Bispecific Antibody-Toxin Conjugate Directed Against CD4 and CD26 (1993) (8)
Internalization of CD 26 by mannose 6-phosphate y insulin-like growth factor II receptor contributes to T cell activation (2000) (8)
Altered tyrosine phosphorylation via the very late antigen (VLA)/beta1 integrin stimulation is associated with impaired T-cell signaling through VLA-4 after allogeneic bone marrow transplantation. (1997) (8)
Phase I study of YS110, a recombinant humanized monoclonal antibody to CD26, in Japanese patients with advanced malignant pleural mesothelioma. (2019) (8)
Human T lymphocyte populations which bind to P- or E-selectin are enriched with cells expressing core 2 O-glycans. (1999) (7)
(MERS-CoV) Infection by Anti-CD26 Monoclonal Antibody (2013) (7)
CD26: a key molecule in immune regulation and autoimmune diseases (2003) (7)
Crosslinking CD3 with CD2 using sepharose-immobilized antibodies enhances T lymphocyte proliferation. (1988) (7)
Monoclonal antibody 4B4 blocks suppression of the immune response to Cryptomeria japonica pollen antigen. (1988) (7)
Human GM-CSF induces HIV-1 LTR by multiple signalling pathways. (2002) (7)
CD 27-CD 70 interactions regulate B-cell activation by T cells ( tumor necrosis factor receptor family / immunoregulation ) (2005) (7)
Targeting CD26 suppresses proliferation of malignant mesothelioma cell via downmodulation of ubiquitin-specific protease 22. (2018) (6)
Tissue- and context-dependent modulation of hormonal sensitivity of glucocorticoid-responsive genes by hexamethylene bisacetamide-inducible protein 1. (2008) (6)
IL-26 mediates epidermal growth factor receptor-tyrosine kinase inhibitor resistance through endoplasmic reticulum stress signaling pathway in triple-negative breast cancer cells (2021) (6)
DPP4 (dipeptidyl-peptidase 4) (2013) (6)
Definition of the T-lymphocyte inducer of suppression in primates using a monoclonal antibody. (1985) (6)
An adult case of Henoch-Schönlein purpura complicating common peroneal nerve mononeuropathy (2009) (6)
SHP-2 inhibits tyrosine phosphorylation of Cas-L and regulates cell migration. (2009) (6)
Current and Emerging Therapy for Malignant Pleural Mesothelioma: Focus on CD26/Dipeptidyl Peptidase IV as a Therapeutic Target (2017) (6)
Characterization of the CD8+CD45R+(2H4+) suppressor effector cell. (1989) (6)
Intestinal epithelial cells express and secrete the CD43 glycoform that contains core 2 O-glycans. (2001) (6)
Association of CD 26 with CD 45 RA outside lipid rafts attenuates cord blood T-cell activation (2004) (5)
Role of the β1 integrin molecule in T-cell activation and migration (2000) (5)
Amplification of suppressor inducer pathway with monoclonal antibody, anti-2H4, identifying a novel epitope of the common leukocyte antigen/T200 antigen. (1989) (5)
Double-label immunochemical analysis of T-cell activation markers and MHC expression in active multiple sclerosis lesions (1987) (5)
Recognition of cell surface GD3 by monoclonal antibody anti-6C2 in rheumatoid arthritis synovial fluid: expression on human T cells with transendothelial migratory activity. (2001) (5)
Immunohistochemical analysis of suppressor-inducer and helper-inducer T cells in multiple sclerosis brain tissue (1987) (5)
Role of IL-26+CD26+CD4 T Cells in Pulmonary Chronic Graft-Versus-Host Disease and Treatment with Caveolin-1-Ig Fc Conjugate. (2016) (5)
Beta 1 integrin-mediated signaling in human T cells. (1996) (5)
Effector memory CD4+T cells in mesenteric lymph nodes mediate bone loss in food-allergic enteropathy model mice, creating IL-4 dominance (2021) (4)
Development of novel monoclonal antibodies with specific binding affinity for denatured human CD26 in formalin-fixed paraffin-embedded and decalcified specimens (2019) (4)
Hapten-specific carrier-dependent tolerance induction in man in vitro. (1983) (4)
Functional Differences of Anti‐T‐Cell Antibody in Patients with Systemic Lupus Erythematosus and Ulcerative Colitis (1983) (4)
Transforming growth factor-β-induced CUX1 isoforms are associated with fibrosis in systemic sclerosis lung fibroblasts (2016) (4)
The Development of Monoclonal Antibodies against Human Immunoregulatory T Cell Subsets: The Isolation of Human Suppressor Inducer T Cell Subset (1986) (4)
The role of Cas-L/NEDD9 as a regulator of collagen-induced arthritis in a murine model. (2015) (4)
Phase 2 Study of YS110, a Recombinant Humanized Anti-CD26 Monoclonal Antibody, in Japanese Patients With Advanced Malignant Pleural Mesothelioma (2021) (4)
DNA-daunorubicin complexes specifically suppress in vitro spontaneous anti-DNA antibody production in lymphocytes of patients with systemic lupus erythematosus. (1986) (4)
Targeting of an activated T-cell subset using a bispecific antibody-toxin conjugate directed against CD4 and CD26. (1993) (3)
Expression of CD 26 and Its Associated Dipeptidyl Peptidase IV Enzyme Activity Enhances Sensitivity to Doxorubicin-induced Cell Cycle Arrest at the G 2 / M Checkpoint 1 (2001) (3)
Peripheral blood T-lymphocytes during the course of systemic lupus erythematosus. (1975) (3)
Selective modulation of glucocorticoid receptor function toward development of novel antiinflammation: lessons from a phenylpyrazolosteroid cortivazol (2004) (3)
Microscopic polyangiitis initiated with liver dysfunction, calf pain and fever of unknown origin (2010) (3)
Characteristic and functional specificity of anti-human BAT (brain associated thymocyte antigen) serum. (1980) (3)
Differential regulation of CD27 expression on subsets of CD4 T cells. (1994) (3)
Peripheral endomorphins drive mechanical alloknesis under the enzymatic control of CD26/DPPIV. (2021) (3)
Modulation of immunological responses and amelioration of collagen-induced arthritis by the novel roxithromycin derivative 5-I (2015) (3)
Chapter 1 – Use of Monoclonal Antibodies in the Study of Autoimmunity and Immunodeficiency1 (1983) (3)
Establishment of anti-mesothelioma monoclonal antibodies (2016) (2)
Surrogate thrombopoietin. (1998) (2)
Cell-mediated immunity to platelets in SLE patients with thrombocytopenia: two different types of lymphocyte stimulation. (1980) (2)
Corrigendum to “Characterization of cancer stem cell properties of CD24 and CD26-positive human malignant mesothelioma cells” [Biochem. Biophys. Res. Commun. 419 (2012) 529–536] (2012) (2)
[Antibody therapy for malignant mesothelioma: humanized anti-cD26 mAb therapy]. (2012) (2)
CD26 Is a Novel Target for the Treatment of Tumor Progression and Its Related Osteolytic Bone Disease in Multiple Myeloma (2015) (2)
Anti-Human CD9 Fab Fragment Antibody Blocks the Extracellular Vesicle-Mediated Increase in Malignancy of Colon Cancer Cells (2022) (2)
A Novel Mechanism for Imatinib Mesylate (STI571) Resistance in CML Cells: Contribution of TC-PTP to Modulating Signals Down-Stream from the BCR-ABL Fusion Protein. (2004) (2)
CD26 Blockade by Humanized Monoclonal Antibody Leads to Prophylaxis and Treatment of Graft-Versus-Host Disease (GVHD) in Hu-PBL-NOG Model Mice, (2011) (2)
3H11, a unique cell surface molecule involved in the function of the CD45RA+ subset of CD4+ cells. (1994) (2)
First-in-human phase I administration of YS110, a monoclonal antibody directed against the CD26 immunostimulatory molecule in advanced cancer patients. (2015) (2)
[Targeted therapy by monoclonal antibodies]. (2010) (2)
Stimulation of Tyrosine Phosphorylation After Ligation of p 7 and pl Integrins on Human B Cells (2002) (2)
Knockdown of XAB 2 Enhances All-Trans Retinoic Acid – Induced Cellular Differentiation in All-Trans Retinoic Acid – Sensitive and – Resistant Cancer Cells (2007) (2)
[T cell receptor and its related molecules in signal transduction]. (1999) (2)
Rapid inhibitory effect of tacrolimus on T cell migration by suppressing CD29-related functions. (2004) (2)
Selective immunomodulation: utilization of CD29/VLA molecules. (1996) (2)
Predictive Biomarkers and Personalized Medicine CD 26 Overexpression Is Associated with Prolonged Survival and Enhanced Chemosensitivity in Malignant Pleural Mesothelioma (2012) (2)
A Novel Function of CD26-Mediated Costimulation in the Cytotoxic Activity of Human CD8+ T Cells in Xenogeneic Chronic Graft-Versus-Host Disease (cGVHD) and GVL Mice Model. (2009) (2)
Serum soluble CD26/DPP4 titer variation is a potential prognostic biomarker in cancer therapy with a humanized anti-CD26 antibody (2020) (2)
CD26+ Lymphocytes and serum soluble CD26/ Dipeptidyl peptidase IV are involved in the Pathogenesis of Crohnʼs Disease: P-0131. (2009) (2)
Cas-L Is Required for β1 Integrin-Mediated Costimulation in Human T Cells (1999) (2)
The human immunoregulatory T cell circuit: recent progress and its clinical implications. (1987) (2)
A humanized anti-CD26 monoclonal antibody inhibits cell growth of malignant mesothelioma via retarded G2/M cell cycle transition (2016) (1)
Gene expression microarray data from mouse CBS treated with rTMS for 30 days, mouse cerebrum and CBS treated with rTMS for 40 days (2018) (1)
Effect of H1‐receptor antagonists on proliferative response, cytokine production, and cellular migration of human T cells and macrophages (2008) (1)
Gene expression microarray data from mouse cerebrum treated with rTMS for 30 days (2017) (1)
Immunohistochemical Analysis of Suppressor‐Inducer and Helper‐Inducer T Cells in Multiple Sclerosis Brain Tissue (1988) (1)
Peripheral T Cells under Hypoxic Conditions in Human Synthesis via Rapamycin-Sensitive Pathway Protein α Hypoxia-Inducible Factor-1 TCR Engagement Increases (2005) (1)
Direct demonstration of the function of T cell subsets reactive with anti-T cell antibodies from SLE sera (1982) (1)
[Development of New Therapy for Malignant Mesothelioma Based on CD26 Molecule]. (2016) (1)
Humanized anti‐IL‐26 monoclonal antibody as a novel targeted therapy for chronic graft‐versus‐host disease (2022) (1)
Targeting CD26 with Humanized Monoclonal Antibody, As a Novel Approach to Inhibit Human Osteoclast Differentiation and Subsequent Bone Resorption (2012) (1)
Strategic targeting of the glucocorticoid receptor for anti-inflammation (2007) (1)
Enhancement of lymphocyte response to PHA by lysosomal enzymes from polymorphonuclear leukocytes of RA joint fluid (1980) (1)
Data on CUX1 isoforms in idiopathic pulmonary fibrosis lung and systemic sclerosis skin tissue sections (2016) (1)
[Role of Cas-L in beta 1 integrin mediated T cell activation]. (1999) (0)
Humanized Anti-CD26 Monoclonal Antibody Inhibits Osteoclast Bone Resorption Activity Via Blockade Of P38MAPK Signaling In Multiple Myeloma (2013) (0)
Atlas of Genetics and Cytogenetics in Oncology and Haematology DPP 4 ( dipeptidyl-peptidase 4 ) (2013) (0)
Direct Associat ion o f pp 125 Fpa ~ with PaxiUin , the Focal Adhes ion-target ing Mechanism (2003) (0)
Monocyte dependent and independent in vitro regulation of granulocyte macrophage colony forming units by subpopulations of peripheral blood t cells (1985) (0)
Leukemia Relapse Mice from Acute Graft-versus-Host Disease TRAIL-Transduced Dendritic Cells Protect (2005) (0)
This information is current as Up-Regulation on APCs Induces T Cell Proliferation Through CD 86 Soluble CD 26 / Dipeptidyl Peptidase IV (2001) (0)
Negative regulation of the hypoxia-inducible transcription factors by IPAS defines a novel anti-angiogenesis therapeutic strategy (2003) (0)
Protein kinase A-mediated phosphorylation of the T-cell surface antigen CD27. (1993) (0)
Induces Profound Apoptosis of Human Respiratory Syndrome Coronavirus Bilateral Entry and Release of Middle East (2014) (0)
First-In-Human Phase I Administration of YS110, A Humanized Monoclonal Antibody Directed Against the CD26 Molecule in Cancer Patients (2012) (0)
Establishment of anti-mesothelioma monoclonal antibodies (2016) (0)
Cd4 positive cd45r positive and cd45r negative subsets in man remain distinct after activation with con a (1989) (0)
CD26 Expression on T-Anaplastic Large Cell Lymphoma (ALCL) Line Karpas 299 is associated with increased expression of Versican and MT1-MMP and enhanced adhesion (2013) (0)
CD26/DPPIV-mediated regulation of pruritus in psoriasis (2017) (0)
A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes (1989) (0)
[Effect of H1 histamine receptor antagonists on T cell functions]. (2003) (0)
Responsiveness of Cord Blood T Cells Chemokine Receptor Expressions and (0)
[Beta 1 integrin molecule and its immunoregulatory function of T cells]. (1999) (0)
CCL 5 T Cells to CCL 3 and + Human Naive CD 4 Associated with the Hyporesponsiveness of and a Deficiency of CCR 5 Expression Are EventCCR 1-Mediated Downstream Signaling (2002) (0)
Abstract 3390: Cas-L promotes migration, invasion and recurrence in human lung cancer (2010) (0)
CD26 Expression on T-Cell Lines Is Associated with SDF-1α-Mediated Invasion and Phosphorylation of Signaling Molecules. (2007) (0)
Cas-L associates with human T-lymphotropic virus type I Tax and regulates its transactivation of NF-κB: possible role of Cas-L in pathophysiology of rheumatoid arthritis (2003) (0)
Large Cell Lymphoma Karpas 299 Extracellular Matrix , and Tumorigenicity of T-Anaplastic , Adhesion to 1 β Dependent Phosphorylation of Integrin − CD 26 Regulates p 38 Mitogen-Activated Protein Kinase (2005) (0)
Humanized Anti-CD26 Monoclonal Antibody Has Anti-Myeloma Efficacy for the Treatment of High-Risk Multiple Myeloma (2017) (0)
Human Naive CD4+ T Cells to CCL3 and Associated with the Hyporesponsiveness of and a Deficiency of CCR5 Expression Are Event CCR1-Mediated Downstream Signaling An Abortive Ligand-Induced Activation of (2013) (0)
CD26/Dipeptidyl Peptidase IV (DPPIV) Regulates p38 Phosphorylation and Topoisomerase II Alpha Expression in the B-Lymphoma Line Jiyoye, Associated with Enhanced In Vitro and In Vivo Sensitivity to Doxorubicin. (2004) (0)
BETA.1 integrin and signal transduction. (1993) (0)
Functional roles of CD26/DPP4 in bleomycin‐induced pulmonary fibrosis (2023) (0)
Methodes d'identification d'agents immunoregulateurs, agents immunoregulateurs, et utilisations associees (2004) (0)
Anti-glomerular Basement Membrane Disease Concomitant with MPO-ANCA Positivity Concurrent with High Serum Levels of Interleukin-26 Following Coronavirus Disease 2019 Vaccination (2023) (0)
Characterization of Cancer Stem Cells in Human B-Cell Lymphoid Hematologic Malignancies. (2007) (0)
factors Response patterns of purified myeloma cells to hematopoietic growth (2011) (0)
Costimulatory Pathway forIL-10 as Potential Regulatory Mechanism CD 26-Mediated Induction of EGR 2 and Chikao (2014) (0)
Lymphocytes CD4 T + CD26 + Disease by IL-26 Regulation of Pulmonary Graft-versus-Host (2015) (0)
Monoclonal antibodies and immunization it. (1985) (0)
Role of β1 integrin and its signaling molecule, Cas-L, in pathophysiology and therapeutic interventigens of rheumatoid arthritis (2003) (0)
blood T-cell activation Association of CD26 with CD45RA outside lipid rafts attenuates cord (2013) (0)
Role of the CD 26 antigen in T cell activation (1991) (0)
Up-Regulation on APCs Induces T Cell Proliferation Through CD86 Soluble CD26/Dipeptidyl Peptidase IV (2001) (0)
Anti-CD26 humanized monoclonal antibody conjugated to triptolide is transported into nucleus and impairs RNA polymerase II (2017) (0)
[CD26 and its signaling pathway]. (2012) (0)
Strategies for specific immunomodulation in transplantation (1994) (0)
Heterogeneity of lymphocyte function in patients with idiopathic thrombocytopenic purpura. (1983) (0)
A monoclonal antibody which distinguishes between helper lymphocyte-inducer and suppressor-inducer CD4 + (1990) (0)
M Checkpoint 2 Cell Cycle Arrest at the G Enzyme Activity Enhances Sensitivity to Doxorubicin-induced Expression of CD 26 and Its Associated Dipeptidyl Peptidase IV Updated (2001) (0)
beta1 integrins on human B cells Stimulation of tyrosine phosphorylation after ligation of beta7 and (2011) (0)
of Antigen Receptor-Driven T Cells Hypoxia-Inducible Factor Regulates Survival (2003) (0)
Monocyte-Derived Dendritic Cells IL-12 Receptor in Human Peripheral Blood IL-12 Responsiveness and Expression of Juji (2000) (0)
Physiological Responses of Sanitary Napkin on Autonomic and Central Nervous and Immune Systems(Proceedings of 6th International Congress of Physiological Anthropology) (2002) (0)
[Transplantation surgery and immune regulation]. (2000) (0)
Role of PTP in immune response - Association of CD26 with CD45 phosphatase in T cell activation. (1996) (0)
Lymphocyte Activation: Modulatory Effects Mediated by Interactions between Cell Adhesion Molecules (1988) (0)
[T cell subset--recent progress and clinical implication]. (1986) (0)
Use of roxithromycin or its derivatives for the modulation of immune responses (2004) (0)
LPS-Induced Lung Injury Is Attenuated in CD26/DPP4 Deficient Mice (2021) (0)
Abstract 4338: Clinical significance of soluble CD26 in malignant pleural mesothelioma (2015) (0)
[Analysis of T cell subsets with monoclonal antibodies]. (1997) (0)
T1229 Mucosal CD4+ T Lymphocytes with High CD26 Surface Expression Are Enriched for Memory/Effector Cells and Involved in the Pathogenesis of Inflammatory Bowel Disease (2008) (0)
Targeting of an Activated Tce l l Subset Using a Bispecific Antibody-Toxin Conjugate Directed Against CD 4 and CD 26 (0)
First-in-human phase 1 of YS110, a monoclonal antibody directed against CD26 in advanced CD26-expressing cancers (2017) (0)
DISSECTION OF HUMAN IMMUNOREGULATORY T LYMPHOCYTES: IMPLICATIONS FOR UNDERSTANDING CLINICAL DISEASE (1983) (0)
Serum soluble CD26/DPP4 titer variation is a potential prognostic biomarker in cancer therapy with a humanized anti-CD26 antibody (2021) (0)
DPP8 Selective Inhibitor Tominostat as a Novel and Broad-Spectrum Anticancer Agent against Hematological Malignancies (2023) (0)
Human CD4 HelperT CellActivation : FunctionalInvolvementofTwo DistinctCollagen Receptors,1177and VLA IntegrinFamily (1990) (0)
CD26 is a potential therapeutic target by humanized monoclonal antibody for the treatment of multiple myeloma (2018) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Chikao Morimoto?

Chikao Morimoto is affiliated with the following schools:

Chikao Morimoto's Academic­Influence.com Rankings

Chikao Morimoto's Degrees

Similar Degrees You Can Earn

Why Is Chikao Morimoto Influential?

Chikao Morimoto's Published Works

Published Works

What Schools Are Affiliated With Chikao Morimoto?

Chikao Morimoto's AcademicInfluence.com Rankings